Beth Levy

4.0k citations

55 papers · 3.3k · h-index 33

Impact in

Physiology top 0.5%
- Lysosomal Storage Disorders Research
Cell Biology top 2%
- Cellular transport and secretion

Papers in

Physiology 36
- Lysosomal Storage Disorders Research 36
Epidemiology 17
- Trypanosoma species research and implications 12

Co-authors: Carole Vogler (34 shared papers)Mark S. Sands (19 shared papers)William S. Sly (19 shared papers)Nancy Galvin (16 shared papers)E H Birkenmeier (9 shared papers)Jeffrey H. Grubb (8 shared papers)Jane E. Barker (9 shared papers)Babette Gwynn (4 shared papers)
Journals: Proceedings of the National Academy of Sciences (5 papers)Pediatric Research (4 papers)Molecular Therapy (4 papers)Blood (3 papers)Journal of Clinical Investigation (3 papers)
Partner nations: United States Belgium United Kingdom

In The Last Decade

Beth Levy

55 papers receiving 3.2k citations

Peers

Countries citing papers authored by Beth Levy

Since Specialization

Citations

This map shows the geographic impact of Beth Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Levy more than expected).

Fields of papers citing papers by Beth Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Levy. The network helps show where Beth Levy may publish in the future.

Co-authors

The 25 scholars most cited alongside Beth Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beth Levy Line = papers co-authored together Beth Levy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease Proceedings of the National Academy of Sciences ·Thomas M. Daly, Carole Vogler, Beth Levy, Mark E. Haskins, Mark S. Sands	1999	177
2	Enzyme replacement therapy for murine mucopolysaccharidosis type VII. Journal of Clinical Investigation ·Mark S. Sands, Carole Vogler, John W. Kyle, Jeffrey H. Grubb, Beth Levy, Nancy Galvin, William S. Sly, E H Birkenmeier	1994	176
3	Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation Blood ·EH Birkenmeier, JE Barker, CA Vogler, JW Kyle, WS Sly, Babette Gwynn, Beth Levy, C Pegors	1991	159
4	Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. PubMed ·Mark S. Sands, Jane E. Barker, Carole Vogler, Beth Levy, Babette Gwynn, Nancy Galvin, William S. Sly, E H Birkenmeier	1993	146
5	Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII Proceedings of the National Academy of Sciences ·Carole Vogler, Beth Levy, Jeffrey H. Grubb, Nancy Galvin, Yun Tan, Emil Kakkis, Nadine Pavloff, William S. Sly	2005	145
6	Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluid Molecular Genetics and Metabolism ·Patricia Dickson, Michael F. McEntee, Carole Vogler, Steven Q. Le, Beth Levy, Maryn Peinovich, Stephen R. Hanson, Merry Passage, Emil Kakkis	2007	141
7	Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I Molecular Genetics and Metabolism ·Emil Kakkis, Michael F. McEntee, Carole Vogler, Si-Hung Le, Beth Levy, Pavel V. Belichenko, William C. Mobley, Patricia Dickson, Stephen R. Hanson, Merry Passage	2004	135
8	A murine model of mucopolysaccharidosis VII. Gross and microscopic findings in beta-glucuronidase-deficient mice. PubMed ·Carole Vogler, E H Birkenmeier, William S. Sly, Beth Levy, C Pegors, John W. Kyle, Wesley G. Beamer	1990	127
9	Overexpression of sigma receptors in nonneural human tumors. PubMed ·(unknown), Gail E. Thomas, James Y. Mamone, Sharon M. Homan, Beth Levy, Frank E. Johnson, Carmine Coscia	1991	124
10	Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation. Journal of Clinical Investigation ·Mark S. Sands, Carole Vogler, Anna C Torrey, Beth Levy, Babette Gwynn, Jeffrey H. Grubb, William S. Sly, E H Birkenmeier	1997	109
11	Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function. Journal of Clinical Investigation ·Lynn H. O’Connor, Lawrence C. Erway, Carole Vogler, William S. Sly, Andrew Nicholes, Jeffrey H. Grubb, S W Holmberg, Beth Levy, Mark S. Sands	1998	101
12	Chemically modified β-glucuronidase crosses blood–brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII Proceedings of the National Academy of Sciences ·Jeffrey H. Grubb, Carole Vogler, Beth Levy, Nancy Galvin, Yun Tan, William S. Sly	2008	99
13	Intracranial Injection of Recombinant Adeno-associated Virus Improves Cognitive Function in a Murine Model of Mucopolysaccharidosis Type VII Molecular Therapy ·William A. Frisella, Lynn H. O’Connor, Carole Vogler, Marie S. Roberts, Steve Walkley, Beth Levy, Thomas M. Daly, Mark S. Sands	2001	98
14	Enzyme Replacement with Recombinant β-Glucuronidase in the Newborn Mucopolysaccharidosis Type VII Mouse Pediatric Research ·Carole Vogler, Mark S. Sands, A Higgins, Beth Levy, Jeffery Grubb, E H Birkenmeier, William S. Sly	1993	90
15	Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis Neurobiology of Disease ·Megan A. Griffey, Ellen Bible, Carole Vogler, Beth Levy, Praveena Gupta, Jonathan D. Cooper, Mark S. Sands	2004	88
16	Enzyme Replacement with Recombinant β-Glucuronidase in Murine Mucopolysaccharidosis Type VII: Impact of Therapy during the First Six Weeks of Life on Subsequent Lysosomal Storage, Growth, and Survival Pediatric Research ·Carole Vogler, Mark S. Sands, Beth Levy, Nancy Galvin, E H Birkenmeier, William S. Sly	1996	85
17	Enzyme Replacement in Murine Mucopolysaccharidosis Type VII: Neuronal and Glial Response to β-Glucuronidase Requires Early Initiation of Enzyme Replacement Therapy Pediatric Research ·Carole Vogler, Beth Levy, Nancy Galvin, Constance Thorpe, Mark S. Sands, Jane E. Barker, Jack Baty, E H Birkenmeier, William S. Sly	1999	84
18	AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2 Molecular Therapy ·Dar‐Shong Lin, Corinne R. Fantz, Beth Levy, Mohammad A. Rafi, Carole Vogler, David A. Wenger, Mark S. Sands	2005	84
19	Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features Journal of neurosurgery ·(unknown), Dan X. Cai, Dennis J. Rivet, Bruce A. Kaufman, T. S. Park, Beth Levy, Arie Perry	2001	82
20	A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors Human Pathology ·Leslie A. Bruch, Debbie Hill, Dan X. Cai, Beth Levy, Louis P. Dehner, Arie Perry	2001	75

About Beth Levy

Beth Levy is a scholar working on Physiology, Epidemiology, Rheumatology, Cell Biology and Molecular Biology, having authored 55 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lysosomal Storage Disorders Research (36 papers), Trypanosoma species research and implications (12 papers), Cellular transport and secretion (11 papers), Glycogen Storage Diseases and Myoclonus (9 papers), Hematopoietic Stem Cell Transplantation (5 papers), Carbohydrate Chemistry and Synthesis (4 papers), RNA regulation and disease (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). The work is most often cited by research in Physiology (2.1k citations), Physiology (267 citations), Cell Biology (597 citations), Genetics (328 citations) and Epidemiology (797 citations). Beth Levy has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Carole Vogler, Mark S. Sands, William S. Sly, Nancy Galvin, E H Birkenmeier, Jeffrey H. Grubb, Jane E. Barker, Babette Gwynn, Thomas M. Daly and Emil Kakkis. Their work appears in journals such as Proceedings of the National Academy of Sciences, Pediatric Research, Molecular Therapy, Blood and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Beth Levy

Impact in

Papers in i

In The Last Decade

Beth Levy

Peers

Countries citing papers authored by Beth Levy

Fields of papers citing papers by Beth Levy

All Works

About Beth Levy

Explore authors with similar magnitude of impact

Papers in